Telix Pharmaceuticals Limited (TLPPF)
OTCMKTS · Delayed Price · Currency is USD
15.90
+0.13 (0.81%)
Jul 18, 2025, 3:31 PM EDT
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $5.58 billion as of July 18, 2025. Its market cap has increased by 33.74% in one year.
Market Cap
5.58B
Enterprise Value
5.49B
Revenue
484.69M
Ranking
n/a
PE Ratio
180.57
Stock Price
$15.90
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 115.28M to 5.58B, an increase of 4,739.01%. That is a compound annual growth rate of 65.78%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 782.91M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 567.50M |
| Glass House Brands | 426.27M |
| Northwest Biotherapeutics | 388.86M |
| CytoDyn | 380.38M |